Celcuity Inc.

General ticker "CELC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $536.9M (TTM average)

Celcuity Inc. does not follow the US Stock Market performance with the rate: -2.4%.

Estimated limits based on current volatility of 2.8%: low 10.78$, high 11.40$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [7.56$, 17.44$]
  • 2025-12-31 to 2026-12-31 estimated range: [4.91$, 12.05$]

Financial Metrics affecting the CELC estimates:

  • Negative: Non-GAAP EPS, $ of -2.61 <= 0.04
  • Positive: 43.26 < Shareholder equity ratio, % of 47.17 <= 63.75
  • Negative: Operating cash flow per share per price, % of -14.33 <= 1.79
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Positive: -3.20 < Investing cash flow per share, $ of -1.60

Similar symbols

Short-term CELC quotes

2025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-257.588.599.51010.51111.5
Price $

Long-term CELC plot with estimates

46810121416182022Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.8−0.6−0.4−0.20
CELCS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $39.39MM $66.23MM $113.27MM
Operating Income $-39.39MM $-66.23MM $-113.27MM
Non-Operating Income $-0.98MM $2.45MM $1.49MM
Interest Expense $2.11MM $5.33MM $10.28MM
R&D Expense $35.29MM $60.59MM $104.20MM
Income(Loss) $-40.37MM $-63.78MM $-111.78MM
Profit(Loss)* $-41.35MM $-63.78MM $-111.78MM
Stockholders Equity $133.77MM $139.77MM $115.62MM
Inventory $0.20MM $0.00MM $8.63MM
Assets $175.70MM $191.22MM $245.12MM
Operating Cash Flow $-36.01MM $-53.81MM $-83.47MM
Capital expenditure $0.16MM $0.10MM $0.25MM
Investing Cash Flow $-144.03MM $-5.01MM $-63.07MM
Financing Cash Flow $120.33MM $64.91MM $138.39MM
Earnings Per Share** $-2.68 $-2.69 $-2.83

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.